03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Apo-Rosuvastatine 20mg : | |
Type | Medicine Authorised |
Originator | Crestor 20mg |
Agent | Promopharm |
Distributor | Promopharm |
Laboratory | Apotex |
Responsible Party | Apotex Inc |
Origin | Canada |
Manufacturer | Apotex Inc |
Manufacturing Type | G |
Origin | Canada |
ATC | C10AA07 |
Apo-Rosuvastatine 20mg :
Apo-Rosuvastatine 20mg :
Apo-Rosuvastatine 20mg :
Apo-Rosuvastatine 20mg :
Apo-Rosuvastatine 20mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Apo-Rosuvastatine 20mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Arthralgia (Pain joint) (Joint ache) | Very rare |
Asthenia | Common |
Cephalea | Common |
Constipation | Common |
Cough | Not known |
Depression | Not known |
Diarrhoea (Diarrhea) | Not known |
Dizziness | Common |
Dyspnoea (dyspnea) | Not known |
Eruption | Uncommon |
Gynecomastia (Gynaecomastia) | Very rare |
Haematuria (Hematuria) | Very rare |
Hepatitis | Very rare |
Hypersensitivity reactions | Rare |
Immune-mediated necrotising myopathy | Not known |
Insomnia | Not known |
Jaundice | Very rare |
Memory impairment | Very rare |
Myalgia | Common |
Myopathy | Rare |
Myositis | Rare |
Nausea | Common |
Neuropathy peripheral | Not known |
Nightmares | Not known |
Oedema | Not known |
Pancreatitis | Rare |
Polyneuropathy | Very rare |
Pruritus | Uncommon |
Rhabdomyolysis | Rare |
Sleep disorder (Sleep disturbance) | Not known |
Stevens-Johnson syndrome | Not known |
Tendon disorder | Not known |
Tendon rupture | Not known |
Thrombocytopenia (Thrombopenia) | Rare |
Transaminases increased | Rare |
Type 2 diabetes mellitus | Common |
Urticaria | Uncommon |
Apo-Rosuvastatine 20mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Apo-Rosuvastatine 20mg MoH 7497 :
Form | Tablet, Film-Coated |
Package Size | Box of 30 |
Strength | 20mg |
Storage Condition | 15-30°C protect from light |
Public Price | 670577.41 L.L. |
Stratum | A1 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 186100/13 |
Submission date | 01/01/2013 |
Registration Year | 2014 |
Price Comparison
● Country: | Czech Republic | |
● Package Size: | 30 | |
● Public Price: | 351.44 CZK | ( 1,342,149.36 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 11,7147 CZK | ( 42,009.00 LBP ) |
● Exfactory Price: | 235.71 CZK | |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 30 | |
● Public Price: | 42.2 SAR | ( 997,608.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 1,4067 SAR | ( 23,640.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Tablet, Film-Coated | |
● Package Size: | Box of 30 | |
● Public Price: | 670577.41 LBP | ( 670,577.41 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 22352,58 LBP | ( 22,352.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Oman | |
● Package Size: | 3x10 | |
● Public Price: | 9.12 OMR | ( 2,104,294.08 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,304 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 28 | |
● Public Price: | 10.3 EUR | ( 997,822.80 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,3679 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 18/05/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Spain | |
● Package Size: | 28 | |
● Public Price: | 21.01 EUR | ( 2,035,364.76 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,7504 EUR | ( 0.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File